Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Prescient Therapeutics Limited ( (AU:PTX) ) has shared an update.
Prescient Therapeutics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, detailing the roles and responsibilities of the board and management, and the processes for appointing directors and senior executives. This announcement signifies the company’s commitment to transparency and accountability, which could enhance its reputation and trust among stakeholders.
More about Prescient Therapeutics Limited
Average Trading Volume: 1,310,368
Technical Sentiment Signal: Sell
Current Market Cap: A$46.81M
See more data about PTX stock on TipRanks’ Stock Analysis page.